Arc Bio LLC

arcbio.com

Arc Bio, a subsidiary of Cantata Bio, specializes in developing innovative metagenomic next-generation sequencing (NGS) solutions for microbial detection. Their flagship product, the Galileo ONE, integrates assay controls and software to streamline the detection and quantification of microorganisms from low abundance samples. By leveraging a proprietary database, Arc Bio provides researchers and clinicians with unprecedented access to genomic information, enabling them to tackle complex scientific challenges in fields such as infectious disease and microbiome analysis. The company's unique approach differentiates it in the competitive landscape of biosciences, positioning it as a leader in the rapidly evolving market of genomic technologies.